<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03947060</url>
  </required_header>
  <id_info>
    <org_study_id>A-2019-028</org_study_id>
    <nct_id>NCT03947060</nct_id>
  </id_info>
  <brief_title>The Alternative Position for the SedLine® Sensor</brief_title>
  <official_title>BI-SENSES: Validation of Nasal Versus Frontal Placement of the SedLine® Sensor Through Processed Electroencephalography in Adult Patients Undergoing General Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cleveland Clinic Abu Dhabi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Masimo Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Cleveland Clinic Abu Dhabi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      SedLine® Brain Function Monitoring provides real-time insight into a patient's depth of
      anesthesia with bilateral data acquisition and processing of electroencephalogram (EEG)
      signals. Four active EEG leads collect data from the frontal lobe with a sensor position on
      the patient's forehead.

      Whenever a frontal approach for neurosurgical procedures is required or the frontal placement
      of the EEG is not indicated, it would not be possible to place the SedLine® .

      Numerous studies have analyzed the change of position and the application of alternative
      positions for other devices used in assessing the depth of anesthesia. Albeit, yet to date,
      there is no study that analyzed the application of alternative positions for the SedLine®
      sensor.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of study is to compare the standard forehead placement versus a nasal placement
      of SedLine® sensor for neuromonitoring.

      The hypothesis is that placing the central sensors in the montage approximately 2 cm below
      the standard recommended placement, across the nasal bridge and then running under the eyes
      to the normal temporal leads placement would put the entire montage out of the operative
      field and would still have corresponding values and EEG signals.

      The primary outcome measure is to monitor and compare processed electroencephalograph (EEG)
      values (PSi- Patient State Index, SEFL- Spectral Edge Frequency Left, SEFR- Spectral Edge
      Frequency Right, SR-Suppression Ratio, EMG-Electromyography, ARTF-Artifact) and EEG
      waveforms, on both sensors (standard-Forehead and alternative-Nasal)

      Other parameters that will be measure are patient demographics (age, sex, surgery, ASA
      status, weight, height, BMI).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Actual">April 1, 2020</completion_date>
  <primary_completion_date type="Actual">February 29, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Validation of nasal SedLine® EEG sensor position for monitoring the depth of anesthesia using processed electroencephalograph values</measure>
    <time_frame>One year</time_frame>
    <description>Determine whether it is possible to apply an alternative SedLine® EEG sensor position in a situation where a standard-forehead position is not possible.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Depth of Anesthesia Monitoring</condition>
  <arm_group>
    <arm_group_label>Nasal &amp; Frontal sensor position</arm_group_label>
    <description>One group of participants with two modes of measurement. First mode is standard frontal placement of the SedLine® sensor. Second mode is alternative nasal placement of the SedLine® sensor.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        For each of the two modes of measurement, 1800 data points per subject (1 reading every 2
        seconds for 1 hour) per hour will be collected. Assuming a maximum interclass correlation
        coefficient of .90, a sample size of 40 patients will be required to test the null
        hypotheses that the two modes of measurement share 95% of their variance via the
        construction of a 95% confidence interval that ranges no more than +/-5%.

        Data from the 2 placements will be compared and analyzed using a Bland-Altman analysis, a
        Scatter plot analysis, and a matched-pair analysis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18 years of age, both genders.

          -  Patients undergoing simple or complex surgery.

          -  American Society of Anesthesiologists Classification (ASA) score I to III.

        Exclusion Criteria:

        American Society of Anesthesiologists Classification (ASA) score IV and V.

          -  Emergency cases

          -  Cognitive/Mentally impaired or unable to provide consent

          -  Previous neurological problems affecting EEG

          -  Dementia

          -  Use of sedative or drugs that can alter EEG readings

          -  Patients under head and neck surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Boris Tufegdzic, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cleveland Clinic Abu Dhabi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic Abu Dhabi</name>
      <address>
        <city>Abu Dhabi</city>
        <country>United Arab Emirates</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Arab Emirates</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 7, 2019</study_first_submitted>
  <study_first_submitted_qc>May 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 13, 2019</study_first_posted>
  <last_update_submitted>July 14, 2020</last_update_submitted>
  <last_update_submitted_qc>July 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cleveland Clinic Abu Dhabi</investigator_affiliation>
    <investigator_full_name>Boris Tufegdzic</investigator_full_name>
    <investigator_title>Asst Prof Dr Boris Tufegdzic</investigator_title>
  </responsible_party>
  <keyword>Depth of anesthesia</keyword>
  <keyword>SedLine® sensor</keyword>
  <keyword>Alternative position</keyword>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 15, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT03947060/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 15, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT03947060/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

